Founded in 1982, LATOXAN is now a leading supplier in this field, selling to pharmaceutical companies, medical research laboratories and drug discovery units throughout the world.
Revolutionizing Life Sciences with Active Peptide Discovery
we are at the forefront of innovation in the life sciences, specializing in the discovery, design, and development of active peptides to advance human health and biotechnology.
Our Mission
We aim to unlock the extraordinary potential of peptides—nature’s versatile molecules—to create solutions that address some of the most pressing challenges in medicine, agriculture, and industrial biotechnology.
What Are Active Peptides?
Active peptides are short chains of amino acids that play crucial roles in regulating biological processes. With their high specificity, stability, and bioactivity, they represent a promising class of compounds for therapeutic and technological applications, ranging from cancer treatment and vaccine development to sustainable agriculture and biomaterials.
Our Expertise
Applications in Focus:
From drug discovery and personalized medicine to crop protection and enzyme design, our peptides address diverse industry needs.
Peptide Discovery:
Using cutting-edge bioinformatics and high-throughput screening technologies, we identify novel peptides with exceptional activity.
Peptide Engineering:
Leveraging molecular biology and synthetic chemistry, we optimize peptides for enhanced stability, potency, and targeted delivery.
Peptoxan® is an innovative program by Latoxan, specializing in the identification and development of bioactive peptides derived from animal venoms. These peptides offer groundbreaking potential for applications in pharmacology, biotechnology, and agricultural sciences. The program leverages Latoxan’s extensive venom library and advanced screening methodologies to accelerate peptide discovery and application development.
The Science Behind Peptoxan
Venoms from diverse species such as snakes, scorpions, spiders, and amphibians are nature's reservoirs of potent bioactive molecules. These peptides, evolved over millions of years, exhibit high specificity and efficacy in targeting physiological pathways. Peptoxan® harnesses this natural diversity through:
Comprehensive Venom Libraries:
- Over 300 distinct venoms sourced from Latoxan’s global network.
- Strict adherence to World Health Organization (WHO) guidelines for venom collection and processing.
High-Throughput Screening (HTS):
- Automated platforms for rapid identification of active peptides with therapeutic or bioengineering potential.
- Screening against diverse biological targets such as ion channels, enzymes, and receptors.
Peptide Characterization:
- Detailed biochemical and biophysical analyses, including mass spectrometry and NMR.
- Activity assays to assess antimicrobial, anticancer, analgesic, or neuroprotective properties.
Key Features of the Peptoxan® Program
Traceability and Quality Assurance:
Latoxan ensures full traceability for every venom source, maintaining high-quality standards throughout the production and discovery pipeline.
Customizable Services:
Tailored solutions to meet specific research or industrial needs, with options for custom venom collections or proprietary screening projects.
Collaborative Opportunities:
Partnerships with academic institutions, biotech companies, and pharmaceutical firms to translate discoveries into practical solutions.
